From: Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV
Clinicopathologic parameters | miR-24 expression | P value | |
---|---|---|---|
High (n = 29) | Low (n = 34) | ||
Gender | Â | Â | Â |
Male | 17 | 21 | 0.799 |
Female | 12 | 13 | Â |
Age (years) | Â | Â | Â |
<60 | 15 | 18 | 0.923 |
≥60 | 14 | 16 |  |
Tumor location | Â | Â | Â |
Distal third | 8 | 8 | 0.310 |
Middle third | 6 | 13 | Â |
Proximal third | 15 | 13 | Â |
WHO classification | Â | Â | Â |
Adenocarcinoma | 25 | 28 | 0.155 |
Signet-ring cell carcinoma | 1 | 5 | Â |
Mucinous adenocarcinoma | 3 | 1 | Â |
Differentiation | Â | Â | Â |
Well, moderately | 15 | 8 | 0.021 |
Poorly | 14 | 26 | Â |
Borrmann classification | Â | Â | Â |
I/II | 11 | 12 | 0.828 |
III/IV | 18 | 22 | Â |
Local invasion | Â | Â | Â |
T1/T2 | 1 | 7 | 0.098 |
T3/T4 | 28 | 27 | Â |
Lymph node metastasis | Â | Â | Â |
No | 6 | 4 | 0.535 |
Yes | 23 | 30 | Â |
Distant metastasis | Â | Â | Â |
No | 28 | 31 | 0.724 |
Yes | 1 | 3 | Â |
TNM stage | Â | Â | Â |
I/II | 7 | 8 | 0.955 |
III/IV | 22 | 26 | Â |